V A Rhodes1. 1. University of Missouri Sinclair School of Nursing, Columbia, USA.
Abstract
PURPOSE/ OBJECTIVES: To promote accurate patient assessment, effective patient teaching, and useful research design and outcomes by defining the concepts of nausea, vomiting, and retching; to review the usefulness of self-care guides in assessing the patient's symptom experience. DATA SOURCES: Journal articles, the author's clinical experiences. DATA SYNTHESIS: The concepts of nausea, vomiting, and retching may be difficult for patients to describe and for nurses to assess. Measurement and assessment methods that accurately reflect the patient's experience are critical. CONCLUSION: Management of the individual symptoms of nausea, vomiting, and retching requires expert ongoing assessment of the patient's symptom experience that extends beyond the clinic or hospital visit. Information about symptom occurrence and distress and about self-care strategies used can play a crucial role in the identification, prevention, and management of symptom experience, with the good of improving the patient's quality of life. IMPLICATIONS FOR NURSING PRACTICE: Effective management of the patient's symptom experience depends on the oncology nurse's ability to differentiate occurrence and distress of the individual symptoms and to implement current knowledge not only of chemotherapy, antiemetic drugs, and nonpharmacologic interventions but of unerring ongoing assessments that lead to cost-effective, clinically useful patient outcomes. Basic scientific knowledge for research, practice, and education necessitates reliable, valid measurement tools that differentiate the components and dimensions of the individual symptoms.
PURPOSE/ OBJECTIVES: To promote accurate patient assessment, effective patient teaching, and useful research design and outcomes by defining the concepts of nausea, vomiting, and retching; to review the usefulness of self-care guides in assessing the patient's symptom experience. DATA SOURCES: Journal articles, the author's clinical experiences. DATA SYNTHESIS: The concepts of nausea, vomiting, and retching may be difficult for patients to describe and for nurses to assess. Measurement and assessment methods that accurately reflect the patient's experience are critical. CONCLUSION: Management of the individual symptoms of nausea, vomiting, and retching requires expert ongoing assessment of the patient's symptom experience that extends beyond the clinic or hospital visit. Information about symptom occurrence and distress and about self-care strategies used can play a crucial role in the identification, prevention, and management of symptom experience, with the good of improving the patient's quality of life. IMPLICATIONS FOR NURSING PRACTICE: Effective management of the patient's symptom experience depends on the oncology nurse's ability to differentiate occurrence and distress of the individual symptoms and to implement current knowledge not only of chemotherapy, antiemetic drugs, and nonpharmacologic interventions but of unerring ongoing assessments that lead to cost-effective, clinically useful patient outcomes. Basic scientific knowledge for research, practice, and education necessitates reliable, valid measurement tools that differentiate the components and dimensions of the individual symptoms.
Authors: Hyo Jung Kim; Sang Won Shin; Eun-Kee Song; Na-Ri Lee; Jun Suk Kim; Jin Seok Ahn; Hwan-Jung Yun; Yo-Han Cho; Keon Uk Park; Si-Young Kim; Joung Soon Jang; Sang-We Kim; Hyun Woo Lee; Se Ryeon Lee; Yang Soo Kim; Soon Nam Lee; Yoon Ho Ko; Hwa Jung Kim; Jin-Hyoung Kang Journal: Oncologist Date: 2015-10-28
Authors: Helen Ki Shinn; Mi Hyeon Lee; Sin Yeong Moon; Sung-Il Hwang; Choon Soo Lee; Hyun Kyoung Lim; Jang-Ho Song Journal: Korean J Anesthesiol Date: 2011-01-28
Authors: Jin Hyoung Kang; Jung Hye Kwon; Yun-Gyoo Lee; Keon Uk Park; Ho Jung An; Joohyuk Sohn; Young Mi Seol; Hyunwoo Lee; Hwan-Jung Yun; Jin Seok Ahn; Ji Hyun Yang; Hunho Song; Dong-Hoe Koo; Jin Young Kim; Gun Min Kim; Hwa Jung Kim Journal: Cancer Res Treat Date: 2020-03-18 Impact factor: 4.679